BACKGROUND Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, is known for its effects on anxiety and depression. It has recently gained increasing interest for its potential therapeutic effects, particularly in patients with advanced cancer. This systematic review and meta-analysis aim to evaluate the effects of psilocybin on adult patients with...
The fields of palliative and holistic Nursing are dedicated to providing comprehensive care for the person, emphasizing special attention to the existential and spiritual aspects of care. Psychedelic-assisted therapy has emerged as a promising approach for symptom management in individuals with serious illnesses, particularly those of existential and spiritual origin. People who undergo...
Revista NeurociênciasMay 28, 2024Mariah Caroline Charafeddine Dias, Rafael Mariano de Bitenocurt
Introdução. A depressão afeta mais de 300 milhões de pessoas globalmente, é considerada uma das principais preocupações de saúde pública, sendo referida como o "mal do século". Caracterizada por diversos sintomas, desde tristeza profunda até pensamentos suicidas, o tratamento convencional envolve o uso de antidepressivos, frequentemente acompanhados de psicoterapia, mas a eficácia é variável e...
Prolonged Grief Disorder (PGD) is distinct from yet related to non-pathologic grief, depression, addiction, and Post-Traumatic Stress Disorder (PTSD) with a prevalence of up to 10% in bereaved populations. Hallmarks of PGD include functional impairment a year or more post-bereavement and intense yearning for the deceased. Current treatments for PGD are typically psychological rather than...
Symptoms of anxiety and depression are common in patients with terminal illness and multiple challenges exist with timely and effective care in this population. Several centres have reported that one dose of the serotonergic psychedelic psilocybin, combined with therapeutic support, improves these symptoms for up to 6 months in this patient group. Drawing upon related therapeutic mechanisms,...
The impact of psychedelic treatment on patients suffering from psychiatric diseases like depression, anxiety, post-traumatic psychiatric disorder (PTSD), and existential distress related to cancer has become very intriguing to psychiatrists in the modern era. Serotonergic psychedelics include Lysergic acid diethylamide (LSD), psilocybin, mescaline, ayahuasca, and methylene-deoxy methamphetamine...
Klassische Psychedelika wie Psilocybin, Lysergsäurediethylamid (LSD), Ayahuasca oder 5-Methoxy-Dimethyltryptamin (5-MeO-DMT) stehen wieder vermehrt im Fokus des psychiatrisch-psychotherapeutischen und neurowissenschaftlichen Interesses. Dies ist vor allem auf aktuelle klinische Studien zurückzuführen, die einen möglichen therapeutischen Nutzen von Psychedelika in der Behandlung verschiedener...
Introduction Psilocybin-assisted therapy (PAT) has demonstrated significant potential in alleviating anxiety, depression, and psychological distress among individuals with terminal illnesses. However, numerous barriers prevent equitable access to this transformative treatment. Objectives This study seeks to gather the perspectives of patients on the waitlist of PAT. Methods Semi-structured...
Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...
Distributed by The Video Project, 145 - 9th St., Suite 230, San Francisco, CA 94103; 800-475-2638Produced by Adam GoldhammerDirected by Adam Goldhammer2023, Streaming, 45 mins Linda’s Last Trip is a heartfelt meditation into 64-year-old patient Linda Patchett’s terminal cancer diagnosis and her corresponding treatment with psilocybin mushrooms. Patchett’s journey delves into friendship, family,...